The tumor suppressor miR-217 is reported to inhibit MALAT1 through the Ago2-mediated pathway in order to inhibit EMT-related metastasis through upregulating E-cadherin and N-cadherin suppression (64). This evidence concerns the gene CDH1 and neoplasm.